No Money, Mo’ Problems: Financial Toxicity in the Realm of Cancer Screening

Authors: Arjun N. Patel MD and Jeffrey M. Sutton MD, FSSO
View More View Less

Disclosures: The authors have disclosed that they have not received any financial consideration from any person or organization to support the preparation, analysis, results, or discussion of this article.

Correspondence: Jeffrey M. Sutton, MD, FSSO, Division of Oncologic and Endocrine Surgery, Department of Surgery, Medical University of South Carolina, 30 Courtenay Drive, Suite 246, Room 236, MSC 295, Charleston, SC 29425. Email: suttojef@musc.edu

View associated content

  • 1.

    Hunter WG, Zafar SY, Hesson A, et al. Discussing health care expenses in the oncology clinic: analysis of cost conversations in outpatient encounters. J Oncol Pract 2017;13:e944956.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Abrams HR, Durbin S, Huang CX, et al. Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med 2021;11:20432054.

  • 3.

    Herriges MJ Jr, Shenhav-Goldberg R, Peck JI, et al. Financial toxicity and its assocication with prostate and colon cancer screening. J Natl Compr Canc Netw 2022;20:981988.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Issa IA, Noureddine M. Colorectal cancer screening: an updated review of the available options. World J Gastroenterol 2017;23:50865096.

  • 5.

    Fisher DA, Princic N, Miller-Wilson LA, et al. Healthcare costs of colorectal cancer screening and events following colonoscopy among commercially insured average-risk adults in the United States. Curr Med Res Opin 2022;38:427434.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Subramanian S, Tangka FKL, Hoover S, et al. Comparison of program resources required for colonoscopy and fecal screening: findings from 5 years of the colorectal cancer control program. Prev Chronic Dis 2019;16:E50.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Bradley CJ, Yabroff KR, Zafar SY, Shih YT. Time to add screening for financial hardship as a quality measure? CA Cancer J Clin 2021;71:100106.

  • 8.

    Edward J, Petermann VM, Eberth JM, et al. Interventions to address cancer-related financial toxicity: recommendations from the field. J Rural Health. Published online December 3, 2021. doi:10.1111/jrh.12637

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Pisu M, Banegas MP, Liang MI, et al. How, when, and with whom should cost of care conversations occur? Preferences of two distinct cancer survivor groups. JCO Oncol Pract 2020;16:e912921.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Henrikson NB, Anderson ML, Dickerson J, et al. The Cancer Financial Experience (CAFE) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship. Trials 2022;23:402.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    McLouth LE, Nightingale CL, Dressler EV, et al. Current practices for screening and addressing financial hardship within the NCI Community Oncology Research Program. Cancer Epidemiol Biomarkers Prev 2021;30:669675.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 502 502 502
PDF Downloads 252 252 252
EPUB Downloads 0 0 0